Optivia provides transporter assays for drug discovery companies. Transporter assays are an important part of preclinical safety assessment. The FDA is particularly interested in them for the potential to cause drug interactions.
Optivia assays are well differentiated from other commercially available services because ours are performed in polarized mammalian cells while other companies use insect vesicles or frog oocytes.
Optivia Biotechnology Website